Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
about
Assessment of pulmonary fibrogenic potential of multiwalled carbon nanotubes in human lung cellsEffects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responsesInteractive effects of cerium oxide and diesel exhaust nanoparticles on inducing pulmonary fibrosisInduction of pulmonary fibrosis by cerium oxide nanoparticlesPreclinical and clinical research on inflammation after intracerebral hemorrhageMatrix metalloproteinase induction of Rac1b, a key effector of lung cancer progressionGammaherpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodentsMatrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasisPotentiated interaction between ineffective doses of budesonide and formoterol to control the inhaled cadmium-induced up-regulation of metalloproteinases and acute pulmonary inflammation in ratsReal-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammationPolymorphisms of the tissue inhibitor of metalloproteinase 3 gene are associated with resistance to high-altitude pulmonary edema (HAPE) in a Japanese population: a case control study using polymorphic microsatellite markersActivation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals.Upregulation of gelatinases and epithelial-mesenchymal transition in small airway remodeling associated with chronic exposure to wood smoke.Role of ADAM and ADAMTS metalloproteinases in airway diseases.ORMDL3 is associated with airway remodeling in asthma via the ERK/MMP-9 pathwayNeutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice.MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets.Psychological factors in asthmaHIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue-Destructive Phenotype.Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF).IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells.HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.Inhibition of airway epithelial-to-mesenchymal transition and fibrosis by kaempferol in endotoxin-induced epithelial cells and ovalbumin-sensitized mice.A novel interplay between Rap1 and PKA regulates induction of angiogenesis in prostate cancer.Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.Identification of neutrophil activation markers as novel surrogate markers of CF lung disease.Does airway smooth muscle express an inflammatory phenotype in asthma?The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthmaEffects of woodsmoke exposure on airway inflammation in rural Guatemalan women.Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.Impact Assessment of Cigarette Smoke Exposure on Organotypic Bronchial Epithelial Tissue Cultures: A Comparison of Mono-Culture and Coculture Model Containing Fibroblasts.Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model.Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstructionFibrotic response as a distinguishing feature of resistance and susceptibility to pulmonary infection with Mycobacterium tuberculosis in micePrognostic significance of gelsolin and MMP12 in Langerhans cell histiocytosis.Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during influenza virus infection.Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzaeAlveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice.
P2860
Q23910072-7D47C1F0-7C3C-42CF-AB53-0E1BB0E29E13Q23914446-7C955A53-17BA-419B-A946-628CE8976001Q23914450-194BC095-831B-49B7-85F1-916D8DEAD614Q23914456-F3920B98-8F7D-444A-A03F-5ACCDEDA7EF3Q24594191-E8153D09-126B-4DDC-BC7D-D2D373852729Q24633879-637A4E51-6441-42E4-8B17-832B2D0CFC1AQ26829291-72A3E05C-BC67-4992-ADE8-C39AF0565EA4Q28256930-BAB04CEA-9370-4A4B-AD85-B9E5AE2551D3Q28654717-7E593AC5-FEAD-4FDB-8E08-39F7E4E959D3Q30484461-D21A556A-868B-4C76-AB38-3B8E626C941CQ31132108-A57DA878-E95E-4B61-82C8-2A084A431E0DQ33289231-166C9944-2EEF-4591-9766-D8AA9149FAFDQ33527440-20DA916B-B5AA-4DD8-9D72-6E084DA523FFQ33573801-B07AEBF8-F445-46F9-8B6B-E7088F8BB1E9Q33587176-129E3272-384F-47EC-8984-FBC129FF9ACAQ33673851-1D884202-E67D-4F6B-A4DD-68ACF4D8DA4CQ33743958-D9C7639C-8B00-41AC-8043-687F7FD8A026Q33815996-F7DC6BF5-7821-46C1-9706-2DF3B434CE11Q33848593-59746DD6-B489-4F80-917E-9242D4311B36Q33923363-07EFDCC3-2316-4AC5-92CC-1F0374591676Q33968772-968DFF4D-2EE4-464E-B0A7-4785E2332E2AQ34116768-ABECB0A1-4350-4D7D-A978-70FFFFBF74D6Q34321838-870F8C40-ED88-42FC-9D9B-00868ADAC583Q34394894-AF872037-10EC-468F-B31B-70E27F382FC4Q34482857-90ED8C98-F886-4BBF-8704-3C67E9DE3895Q34778477-D6E2FD2E-C43C-4A81-9E09-C7B8C8B8A220Q34784319-46634BA6-8F78-40FF-8DFD-20168F902FF1Q34903113-CF1FCAC9-F6D1-4287-BCB6-19BDEEFA31C7Q35080151-9D674E57-E0AF-42C3-8BBE-147D273A4FC7Q35119914-52CFC216-B6B4-49B8-A94D-6A2E96418A93Q35233950-623385C2-4DFD-46DA-9871-CC136C4838E8Q35938029-4F4C7C00-52F8-4CF8-92BA-70C5CE1A4E55Q35995917-C6D5450F-2324-428D-BA07-C7E74C623311Q36203143-8B6CC342-29C9-4889-8C74-23CF0783ED06Q36219151-355EEA26-D4A2-436D-A059-C4EFE807E444Q36422095-2BDD95E4-F748-4E69-B197-4386541DBC76Q36513786-2AEA6468-9D90-4F4E-9C77-EC9DEB56D2BCQ36514344-E182E263-9AAB-466B-91F0-2E184E45FA60Q36539205-9B96C2A2-9BD1-44F2-9A24-175CCD6BF271Q36619374-B523BCAF-1189-445E-827D-931D54EBF587
P2860
Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Matrix metalloproteinases (MMP ...... sthma and other lung diseases.
@ast
Matrix metalloproteinases (MMP ...... sthma and other lung diseases.
@en
type
label
Matrix metalloproteinases (MMP ...... sthma and other lung diseases.
@ast
Matrix metalloproteinases (MMP ...... sthma and other lung diseases.
@en
prefLabel
Matrix metalloproteinases (MMP ...... sthma and other lung diseases.
@ast
Matrix metalloproteinases (MMP ...... sthma and other lung diseases.
@en
P50
P1476
Matrix metalloproteinases (MMP ...... sthma and other lung diseases.
@en
P2093
Maud M Gueders
P304
P356
10.1016/J.EJPHAR.2005.12.082
P407
P577
2006-02-20T00:00:00Z